...the cancer. Massachusetts General Hospital has licensed the technology to Exosome Diagnostics Inc, where Skog is director of research in addition to his duties at the hospital. (Reporting by
Julie Steenhuysen, editing by Patricia Zengerle)
By: Julie Steenhuysen|Date: Nov 16, 2008